| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.0019 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0037 | 1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |